Cross-reactivity of antibodies against interferon beta in multiple sclerosis patients and interference of the JAK-STAT signaling pathway

Interferon beta (IFNβ) therapy has immunogenic properties and induces the development of neutralizing antibodies (NAbs). From the extensive literature focused in the development of NAbs in multiple sclerosis (MS) patients, their ability to cross-react has been deficiently evaluated, despite having i...

Descripción completa

Detalles Bibliográficos
Autores principales: Hurtado-Guerrero, Isaac, Pinto-Medel, Maria Jesus, Urbaneja, Patricia, Rodriguez-Bada, Jose Luis, Ortega-Pinazo, Jesús, Serrano, Pedro, Fernández, Óscar, Leyva, Laura, Oliver-Martos, Begoña
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5707350/
https://www.ncbi.nlm.nih.gov/pubmed/29185487
http://dx.doi.org/10.1038/s41598-017-16828-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5707350/
https://www.ncbi.nlm.nih.gov/pubmed/29185487
http://dx.doi.org/10.1038/s41598-017-16828-x

Ejemplares similares